Chromic picolinate treatment

Details Chromic picolinate treatment Chromic picolinate treatment

1990-07-13

1992-02-11

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

A61K 31555

Patent

active

050876244

ABSTRACT:
The administration of chromic picolinate, preferably in the form of chromic tripicolinate, as a prophylactic or therapeutic agent for controlling various blood serum parameters. In particular, the administration is for controlling blood serum lipid levels, including the lowering of undesirably high blood serum LDL-cholesterol levels and the raising of blood serum HDL-cholesterol levels. Additionally, the administration is for controlling undesirable high blood serum glucose levels, this being particularly applicable for the treatment of maturity-onset diabetes. Additionally, chromic picolinate, preferably in the form of chromic tripicolinate, is administered to facilitate uptake of amino acids by skeletal muscle. Thus chromic picolinate can act as an effective anabolic agent.

REFERENCES:
patent: 2974043 (1961-03-01), Hochberg et al.
patent: 4315927 (1982-02-01), Evans
patent: 4343905 (1982-08-01), Szalay
patent: 4923855 (1990-05-01), Jensen
Garrison et al., The Nutrition Desk Reference, (1985), pp. 18-21.
Recommended Dietary Allowances, 9th Revised Ed., The National Academy of Sciences (1980), pp. 159-161.
Albers, J. J. et al., (1978) Clin. Chem. 24:853-856.
Friedewald, W. T., (1972) Clin. Chem. 18:499-502.
Naito, H. K., (1986) J. Clin. Immunoassay 9:11-20.
Clegg, M. D. and Schroeder, W. A., (1959) J. Amer. Chem. Soc. 81: 6065-6069.
Hills, M. et al., (1979) Brit. Jour. Clin. Pharmacol. 8:7-20.
Newman, W. P. et al., (1986) New England J. of Med. 314:138-144.
Avogaro, P/ et al., (1978) Artery 4:385-394.
Sniderman, A. et al., (1980) Proc. Natl. Acad. Sci. USA 77:604-608.
Riesen, W. F. et al., (1980) Atherosclerosis 37:157-162.
De Backer, G. et al., (1982) Atherosclerosis 42:197-203.
Maciejko, J. J. et al., (1983) New Engl. J. Med. 309:385-389.
Schmidt, S. B. et al., (1985) Am. J. Cardiol. 55:1459-1462.
Kwiterovich, P. O. et al., (1983) Preventive Medicine 12:815-834.
Brunzell, J. D. et al., (1984) Atherosclerosis 4:79-83.
Anderson, R. A. et al., (1985) Amer. J. Clin. Nutr. 41:1177-1183.
Schaller, K. H., (1973) At. Absorption Newsletter 12:147-150.
Evans, G. W., (1980) Pediatric Res. 14:876-880.
Offenbacher, E. G. and Pi-Sunyer, F. X., (1988) Ann. Rev. Nutr. 8:543-563.
Mertz, W., Nutrition Reviews 33(5):129-135. See also Abstract Citations 2535 and 2537, (1975).
Seal, C. J. and Heaton, F. W., (1983) Brit. Journal of Nutrition 50:317-324.
Chemical Abstracts citation 88:163086 (1977).
Toepfer, E. W. et al., J. Agr. Food Chem. 21(1):69-73 (1973).
Anderson, R. A. et al., Federation Proceedings 43:484 (1984).
Gurson, C. T. et al., Amer. J. of Clin. Nutri., 26:988-991 (1973).
Schroeder, H. A., J. Nutrition 88:439-445 (1966).
National Research Council Recommended Daily Allowances, 10th revised Edition, National Academy of Sciences, Washington, D.C. (1989).
Elwood, J. C. et al., J. Amer. Coll. of Nutri. 1:263-274 (1982).
Abraham, A. et al., The Amer. J. of Clin. Nutri. 33:2294-2298 (1980).
Simonoff, M. et al., Biolog. Trace Element Res. 6:431-439 (1984).
Evans, Gary W., International Journal of Biosocial and Medical Research 11(2):163-180 (1989).
Press, R. I. et al., Western Journal of Medicine 152:41-45 (1990).
Nutrition 21 consumer education brochure: "The Prophylactic and Therapeutic Potential of Chromium Picolinate in Diabetes, Hyperlipidemia, Anabolism and Weight Reduction," (1991).
Present Knowledge in Nutrition, 5th Ed. The Nutrition Foundation (1984), pp. 571-582.
Boyle et al., (1977) Southern Med., Jour. 70:1449-1453.
Anderson, R. A., Clin. Physiol. Biochem. 4:31-41 (1986).
Riales, R., in Chromium in Nutrition and Metabolism, (Shapcott and Hubert, Eds., (1979), pp. 199-212.
Newman, H. A. I. et al., (1978) Clin. Chem. 24:541-544.
The Lipid Research Clinics Coronary Primary Prevention Trial Results, (1984) J. A. M. A. (J. Amer. Med. Assn.) 251:351-364.
McCarty, Mark F. Medical Hypothesis 6:1177-1189. (1980).

Affiliated with

Also associated with

Rating

Chromic picolinate treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chromic picolinate treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chromic picolinate treatment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-782036